Commentary on "Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force".

about

Commentary on "Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force".

Item

http://www.wikidata.org/entity/Q55344735

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Commentary on "Consensus Recom ...... us: International Task Force".

@en

Commentary on "Consensus Recom ...... us: International Task Force".

@nl

type

Item

label

Commentary on "Consensus Recom ...... us: International Task Force".

@en

Commentary on "Consensus Recom ...... us: International Task Force".

@nl

prefLabel

Commentary on "Consensus Recom ...... us: International Task Force".

@en

Commentary on "Consensus Recom ...... us: International Task Force".

@nl

P1476

Commentary on "Consensus Recom ...... us: International Task Force".

@en

P2093

S K Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

α-Glucosidase inhibitors and their use in clinical practice

Metformin and its clinical use: new insights for an old drug in clinical practice.

Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies

The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy.

Variations in tissue selectivity amongst insulin secretagogues: a systematic review.

Dipeptidyl peptidase-4 inhibitors: 3 years of experience.

Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review.

P304

158-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/IJEM.IJEM_22_18

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29535953

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5838895

http://www.w3.org/2001/XMLSchema#string